Brussels, Belgium

Nicolas Van Baren


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
7 patents (USPTO):Explore Patents

Nicolas Van Baren: Innovator in Multiple Myeloma Research

Introduction

Nicolas Van Baren, an accomplished inventor based in Brussels, Belgium, has made significant strides in the field of cancer research. With a commendable portfolio of seven patents, he has focused his innovations on diagnosing and treating conditions such as multiple myeloma and leukemia.

Latest Patents

Among his notable contributions are two groundbreaking patents. The first is centered on methods for diagnosing multiple myeloma by determining rejection antigen precursors. This invention leverages the expression of tumor rejection antigen precursors in multiple myeloma, allowing for the diagnosis of the disease through bone marrow samples and providing a means to monitor the disease's progression. The second patent revolves around leukemia-associated genes, detailing their fragments and biologically functional variants. This innovation also includes the development of related polypeptides and antibodies, along with methods and products that assist in diagnosing and treating conditions marked by the expression of specific gene products.

Career Highlights

Nicolas currently works at the Ludwig Institute for Cancer Research Limited, where he continues to advance research in oncology. His efforts have contributed broadly to understanding various forms of malignancies through innovative diagnostic and therapeutic methodologies.

Collaborations

Throughout his career, Nicolas has collaborated with distinguished colleagues, including Thierry R Boon-Falleur and Francis Brasseur. These partnerships have fostered a collaborative environment that supports the development of impactful research in cancer diagnostics and therapies.

Conclusion

In summary, Nicolas Van Baren stands out as an influential inventor in the realm of cancer research. His patents not only enhance our understanding of diseases like multiple myeloma but also pave the way for novel diagnostic and therapeutic strategies. As innovations continue to evolve within the medical field, Van Baren's contributions are poised to make a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…